GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start
Status:
Withdrawn
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study is an international prospective, open-label, multi-center, non-interventional
study. The protocol will allow enrollment of all patients with diagnosis of HCC in whom a
decision to treat with sorafenib has not been made at time of study enrollment. All patients
will be followed-up until withdrawal of consent, lost to follow-up, death, or the end of the
study. Detailed information concerning the past medical/surgical history, performance status,
methods of diagnosis and staging, etc. of patients with HCC will be collected, and practice
patterns of the physicians involved in the care of patients with HCC under real-life
conditions will be evaluated.